Drugs / PRIMVAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02658253 | Jan 2016 → Sep 2018 | malaria | French National Institute of Health and Medical Research | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRIMVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02658253 ↗ |
| Route | Intramuscular | “Volunteers were recruited into four sequential cohorts receiving PRIMVAC intramuscularly at day 0, 28, and 56” PMID 32032566 ↗ Feb 2020 |